Best Peptides for Gut Health
Peptides researched for digestive health, gut lining repair, IBS, and gastrointestinal inflammation.
Understanding Gut Health Peptides
Gut health peptides focus on repairing and protecting the gastrointestinal tract. BPC-157 (Body Protection Compound) was originally derived from gastric juice and shows remarkable GI healing properties in preclinical studies — from ulcers to inflammatory bowel conditions. KPV is an anti-inflammatory tripeptide that targets gut inflammation specifically. LL-37 has antimicrobial properties that may support gut microbiome balance. These peptides represent a growing area of interest for people dealing with leaky gut, IBS, and other digestive issues.
Key Considerations
- BPC-157 has the most preclinical data for gut healing but no human trials
- Oral BPC-157 may have direct local effects on the GI tract
- KPV targets colonic inflammation specifically
- Diet and lifestyle remain foundational for gut health
- Consult a gastroenterologist for serious digestive conditions
FDA Approved Options (7)
Linaclotide
Also: Linzess, Constella
A peptide guanylate cyclase-C agonist for IBS-C and chronic constipation. Works locally in the gut with minimal systemic absorption.
Plecanatide
Also: Trulance
A uroguanylin analog for chronic constipation and IBS-C. Similar to linaclotide but designed to mimic an endogenous peptide.
Semaglutide
Also: Ozempic, Wegovy, Rybelsus
A GLP-1 receptor agonist with multiple FDA approvals including weight loss, T2D, CV risk reduction, and kidney protection. Wegovy pill approved Dec 2025 as first oral GLP-1 for weight loss.
Tirzepatide
Also: Mounjaro, Zepbound, LY3298176
A dual GIP/GLP-1 receptor agonist representing the next generation of incretin-based therapies. Shows superior weight loss compared to semaglutide in head-to-head trials. First medication approved for obstructive sleep apnea.
Liraglutide
Also: Victoza, Saxenda
An FDA-approved GLP-1 receptor agonist for type 2 diabetes and chronic weight management. The predecessor to semaglutide with daily dosing.
Octreotide
Also: Sandostatin, Octreotide LAR
A synthetic somatostatin analog that inhibits multiple hormones. Used for acromegaly, carcinoid tumors, and various GI conditions.
Glucagon
Also: GlucaGen, Baqsimi
A counter-regulatory hormone to insulin. FDA approved for severe hypoglycemia treatment and diagnostic procedures.
Research Peptides (8)
These peptides are being researched but are not FDA approved. They should only be considered for research purposes or under medical supervision.
BPC-157
PreclinicalA synthetic peptide derived from a protein found in human gastric juice. Known for its remarkable tissue healing properties across multiple body systems. FDA classified as Category 2 in 2023, restricting compounding.
KPV
PreclinicalA tripeptide derived from alpha-melanocyte stimulating hormone (α-MSH). Known for potent anti-inflammatory effects, particularly in the gut.
Ovagen
PreclinicalA tripeptide bioregulator (Glu-Asp-Leu) targeting liver and gastrointestinal tissue. Derived from liver tissue extracts, Ovagen modulates gene expression related to detoxification, antioxidant defense, and hepatocellular repair.
LL-37
Clinical TrialsA naturally occurring antimicrobial peptide and the only human cathelicidin. Part of the innate immune system with broad-spectrum antimicrobial activity.
Pentadecapeptide
PreclinicalThe full 15-amino acid sequence that includes BPC-157. While BPC-157 is more commonly discussed, the full pentadecapeptide has similar healing properties derived from gastric juice.
CagriSema
Clinical TrialsA combination of semaglutide and cagrilintide (amylin analog). The most effective weight loss drug candidate, showing 22.7% body weight reduction in Phase 3 trials - superior to any single-agent GLP-1.
KLOW Blend
PreclinicalAn advanced multi-peptide blend combining BPC-157 (10mg), TB-500 (10mg), GHK-Cu (50mg), and KPV (10mg) totaling 80mg per vial. Evolution of the Glow stack with added KPV for enhanced anti-inflammatory and gut health benefits.
Cagrilintide
Clinical TrialsA long-acting amylin analog developed by Novo Nordisk for obesity treatment. Works through a different mechanism than GLP-1 agonists, targeting amylin receptors in the brain to reduce appetite and slow gastric emptying. Shows enhanced weight loss when combined with semaglutide (CagriSema).
Frequently Asked Questions
What is the best peptide for gut health?
BPC-157 is the most researched peptide for gut healing, with extensive animal studies showing repair of ulcers, colitis, and intestinal damage. It was originally isolated from human gastric juice. KPV is also promising for gut inflammation specifically.
Can BPC-157 heal leaky gut?
Preclinical studies show BPC-157 promotes intestinal tissue repair, reduces inflammation, and may help restore gut barrier integrity. However, 'leaky gut' as a diagnosis is debated in mainstream medicine, and human clinical trials for BPC-157 are lacking.
Should I take BPC-157 orally for gut issues?
Oral administration may deliver BPC-157 directly to the GI tract, which some researchers believe provides localized benefits. Subcutaneous injection is the other common route. Both have anecdotal support but lack human clinical data.
Explore Other Goals
Compare Peptides Side-by-Side
Use our comparison tool to evaluate multiple peptides at once.
Looking for a trusted vendor?
Pro members get access to verified vendors with quality standards & exclusive discount codes.
Get Weekly Peptide Research Updates
New peptides, studies, and FDA changes delivered to your inbox.